Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Inc

212.11
-2.7000-1.26%
Post-market: 212.110.00000.00%16:41 EDT
Volume:1.60M
Turnover:338.26M
Market Cap:25.44B
PE:49.92
High:213.88
Open:212.20
Low:207.30
Close:214.81
Loading ...

BRIEF-PTC Q3 Adjusted EPS USD 1.64 Vs. IBES Estimate USD 1.21

Reuters
·
31 Jul

PTC Inc. Reports Q3 2025 Results: Constant Currency ARR Growth of 9.3%, Operating and Free Cash Flow Grow 14%, Raises Guidance for ARR, Free Cash Flow, Revenue, EPS, and Non-GAAP EPS

Reuters
·
31 Jul

PTC Announces Third Fiscal Quarter 2025 Results

THOMSON REUTERS
·
31 Jul

BRIEF-PTC To Accelerate The Design And Simulation Of AI Infrastructure And Complex Products With Nvidia Omniverse

Reuters
·
30 Jul

PTC expands collaboration with Nvidia

TIPRANKS
·
30 Jul

PTC to Accelerate the Design and Simulation of AI Infrastructure and Complex Products With Nvidia Omniverse

THOMSON REUTERS
·
30 Jul

PTC Therapeutics (PTCT) Gets a Buy from Cantor Fitzgerald

TIPRANKS
·
29 Jul

These Analysts Increase Their Forecasts On PTC Therapeutics

Benzinga
·
29 Jul

UBS Adjusts Price Target on PTC Therapeutics to $80 From $71, Maintains Buy Rating

MT Newswires Live
·
29 Jul

Valero Q2 Profit Reaches $714 Million

Motley Fool
·
29 Jul

PTC Therapeutics Receives Buy Rating Following FDA Approval of Sephience and Strategic Market Positioning

TIPRANKS
·
29 Jul

TD Cowen Remains a Hold on PTC Therapeutics (PTCT)

TIPRANKS
·
29 Jul

PTC Therapeutics: Buy Rating Driven by Sephience Approval and Market Strategy

TIPRANKS
·
29 Jul

Positive Outlook for PTC Therapeutics’ Sephience: Strong Market Potential and Revenue Prospects

TIPRANKS
·
29 Jul

PTC Therapeutics price target raised to $46 from $42 at Barclays

TIPRANKS
·
29 Jul

PTC Therapeutics Gains FDA Approval for Sephience

TIPRANKS
·
29 Jul

PTC Therapeutics trading resumes

TIPRANKS
·
29 Jul

PTC Therapeutics Is Maintained at Neutral by Citigroup

Dow Jones
·
29 Jul

Wolfe Adjusts Price Target on PTC to $220 From $170, Maintains Outperform Rating

MT Newswires Live
·
28 Jul

Barclays Remains a Buy on PTC (PTC)

TIPRANKS
·
28 Jul